BST2 Antikörper (N-Term)
-
- Target Alle BST2 Antikörper anzeigen
- BST2 (Bone Marrow Stromal Cell Antigen 2 (BST2))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BST2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human BST2
- Homologie
- Percent identity by BLAST analysis: Human (100%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide from N-Terminus of human BST2 (Q10589, NP_004326). Percent identity by BLAST analysis: Human (100%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product BST2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Handhabung
- Avoid repeat freeze-thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- BST2 (Bone Marrow Stromal Cell Antigen 2 (BST2))
- Andere Bezeichnung
- BST2 (BST2 Produkte)
- Synonyme
- BST2 antikoerper, CD317 antikoerper, TETHERIN antikoerper, 2310015I10Rik antikoerper, Bst-2 antikoerper, C87040 antikoerper, DAMP-1 antikoerper, GREG antikoerper, Damp1 antikoerper, bone marrow stromal cell antigen 2 antikoerper, bone marrow stromal antigen 2 antikoerper, BST2 antikoerper, LOC618737 antikoerper, Bst2 antikoerper
- Hintergrund
-
Name/Gene ID: BST2
Synonyms: BST2, Bone marrow stromal antigen 2, BST-2, CD317 antigen, CD317, HM1.24 antigen, NPC-A-7, TETHERIN - Gen-ID
- 684
- NCBI Accession
- NP_004326
- UniProt
- Q10589
- Pathways
- Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response
-